Flying membrane

Flight membrane

Flying membrane, also known as “celiac syndrome,” is a rare condition that affects people on a gluten-free diet. The disease was first described in 1954, when Italian pediatrician Mantegazza observed that some children with celiac disease and celiac disease also showed regressive changes in the structure of the eyeball. These changes include an inability to flatten the eyeball when examined, as well as a lack of specular reflection in the pupil. In 1970, Rabbani and Mathew confirmed these findings, describing the condition as Pterygium syndrome. A few years later, Goldberg et al. showed a genetic link between the disease and an abnormality in the IKBKG (interferon kinase gamma inhibitor) gene. However, it was not until half a century later that the genetic mechanism of Pterygia syndrome was finally determined. Thus, in 2013, Han et al., using the following genetic analysis, showed that the A117G amino acid mutation in the PTEN proto-oncogene leads to a decrease in Akt1 phosphorylation and causes Pterygium syndrome. Thus, Pten is one of the most likely factors in the Flying membrane. Due to its rarity, research into treating Letheran syndrome is ongoing and in its early stages. Current treatments for Pterygium syndrome include steroids, minocycline analogues, and TNFα inhibitors. Early treatments for Petigisme syndrome included treatment with induction of celiac disease, but this method was exhausted more than 30 years ago. Although the causes of Letheran syndrome are not yet completely clear, there are many opinions about possible mechanisms. There is a lot of additional evidence that external and internal factors can provoke the development of this pathology